Nazem Atassi

Nazem Atassi is a seasoned professional in neurology, currently serving as a Board Member Observer at QurAlis since March 2023 and as Vice President and Global Head of Early Neurology Development at Sanofi since February 2019. At Sanofi, Nazem leads the early neurology team, focusing on advancing clinical programs in neurodegenerative diseases and neuroimmunology. Additionally, Nazem is a Clinical Neurologist specializing in neuromuscular disorders and ALS at Massachusetts General Hospital, where roles also include Co-Director of the Neurological Clinical Research Institute (NCRI) and Principal Investigator for various clinical trials. Concurrently, Nazem holds an Associate Professor position in Neurology at Harvard Medical School. Educational qualifications include an MMSc in Translational Research from Harvard Medical School, an MBA from MIT Sloan School of Management, and an MD from Damascus University.